Reversible Causes of Cognitive Impairment and Dementia
From Neuroscience to Clinical Practice
Herausgeber: Farrer, Thomas J.; Schaefer, Lynn A.
Reversible Causes of Cognitive Impairment and Dementia
From Neuroscience to Clinical Practice
Herausgeber: Farrer, Thomas J.; Schaefer, Lynn A.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This pioneering book covers a broad range of reversible causes of cognitive decline and dementia, ranging from the basic neuroscience of the condition to clinical manifestations, and practice treatment implications.
Andere Kunden interessierten sich auch für
Rebekah Jamieson-Craig (Rebekah Jamieson-Craig is a Lead Clinical PGroup-Based Interventions for 'Understanding Brain Injury'61,99 €
Narinder KapurMemory Disorders in Clinical Practice50,99 €
John StirlingIntroducing Neuropsychology90,99 €
K. Jayasankara ReddyEssentials of Neuropsychology40,99 €
Managing Challenging Behaviour Following Acquired Brain Injury38,99 €
K. Jayasankara ReddyEssentials of Neuropsychology154,99 €
Assessment of Feigned Cognitive Impairment149,99 €-
-
-
This pioneering book covers a broad range of reversible causes of cognitive decline and dementia, ranging from the basic neuroscience of the condition to clinical manifestations, and practice treatment implications.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd
- Seitenzahl: 354
- Erscheinungstermin: 11. September 2025
- Englisch
- Abmessung: 234mm x 156mm x 20mm
- Gewicht: 542g
- ISBN-13: 9781032782935
- ISBN-10: 1032782935
- Artikelnr.: 73871706
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Taylor & Francis Ltd
- Seitenzahl: 354
- Erscheinungstermin: 11. September 2025
- Englisch
- Abmessung: 234mm x 156mm x 20mm
- Gewicht: 542g
- ISBN-13: 9781032782935
- ISBN-10: 1032782935
- Artikelnr.: 73871706
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Thomas J. Farrer is a board-certified clinical neuropsychologist and Assistant Professor at the University of Idaho where he serves as Associate Program Director in the School of Health and Medical Professions. He has published additional books and articles in neuropsychology and has research interests in dementia and neuroepidemiology. Lynn A. Schaefer is a board-certified clinical neuropsychologist and Director of Neuropsychology at Nassau University Medical Center. She is a fellow of the APA and National Academy of Neuropsychology. She has published additional books and articles in neuropsychology and has interests in dementia, brain injury, educational outreach, and decision-making capacity.
1. Introduction: Reversible Conditions and Modifiable Risk Factors for
Dementia Lynn A. Schaefer and Thomas J. Farrer. 2. Etiology Matters:
Potential Reversibility of Mild Cognitive Impairment Sarah E. Cote and Lisa
D. Ravdin. 3. Drugs and Substance Abuse Jakob Thorn, Doug Johnson-Greene,
and Cady Block. 4. Medication Effects: The Cognitive Impact of Drug
Classes, Polypharmacy, and Drug Interactions. Eric Silk and Dawson Hedges
5. Depression and Other Psychiatric Presentations Shawn McClintock and
Allison Gregg. 6. Persistent Pain Yana Suchy, Michelle Gereau Mora, and
Libby A. DesRuisseaux. 7. Metabolic Disorders and Reversible Causes of
Cognitive Dysfunction Margaret E. Wiggins, and Marc A. Norman. 8. Brain
Tumors Jennifer L. Nosker and Michael W. Parsons. 9. Infectious Diseases
and Dementia: Potential Interventions for Prevention and Treatment Morgan
Chase McClellan, Ethan Sage, Jonathan D. Moore, Shawn D. Gale, Dawson W.
Hedges, and Thomas J. Farrer. 10. Normal Pressure Hydrocephalus Drew M.
Hodis, Jennifer S. Shalam, Wei-Qian Wang, and Susan Farella-Busch. 11.
Other Medical Illnesses and Cognitive Impairment Eric M. Watson, Amelia J.
Hicks, and Jacqueline H. Becker. 12. The mpact of Sleep and Sleep Disorders
on Cognitive Health: Reversibility of Cognitive Impairment Associated with
Sleep Disorders Mariya Narizhnaya and Matthew R. Ebben. 13. Concepts of
Multimorbidity in Clinical Neuropsychology Jason W. Krellman and Robert
Leavenworth. 14. Delirium Kirk J. Stucky and Tracy Shannon. 15. Conclusion
and Applications Thomas J. Farrer and FLynn A. Schaefer.
Dementia Lynn A. Schaefer and Thomas J. Farrer. 2. Etiology Matters:
Potential Reversibility of Mild Cognitive Impairment Sarah E. Cote and Lisa
D. Ravdin. 3. Drugs and Substance Abuse Jakob Thorn, Doug Johnson-Greene,
and Cady Block. 4. Medication Effects: The Cognitive Impact of Drug
Classes, Polypharmacy, and Drug Interactions. Eric Silk and Dawson Hedges
5. Depression and Other Psychiatric Presentations Shawn McClintock and
Allison Gregg. 6. Persistent Pain Yana Suchy, Michelle Gereau Mora, and
Libby A. DesRuisseaux. 7. Metabolic Disorders and Reversible Causes of
Cognitive Dysfunction Margaret E. Wiggins, and Marc A. Norman. 8. Brain
Tumors Jennifer L. Nosker and Michael W. Parsons. 9. Infectious Diseases
and Dementia: Potential Interventions for Prevention and Treatment Morgan
Chase McClellan, Ethan Sage, Jonathan D. Moore, Shawn D. Gale, Dawson W.
Hedges, and Thomas J. Farrer. 10. Normal Pressure Hydrocephalus Drew M.
Hodis, Jennifer S. Shalam, Wei-Qian Wang, and Susan Farella-Busch. 11.
Other Medical Illnesses and Cognitive Impairment Eric M. Watson, Amelia J.
Hicks, and Jacqueline H. Becker. 12. The mpact of Sleep and Sleep Disorders
on Cognitive Health: Reversibility of Cognitive Impairment Associated with
Sleep Disorders Mariya Narizhnaya and Matthew R. Ebben. 13. Concepts of
Multimorbidity in Clinical Neuropsychology Jason W. Krellman and Robert
Leavenworth. 14. Delirium Kirk J. Stucky and Tracy Shannon. 15. Conclusion
and Applications Thomas J. Farrer and FLynn A. Schaefer.
1. Introduction: Reversible Conditions and Modifiable Risk Factors for
Dementia Lynn A. Schaefer and Thomas J. Farrer. 2. Etiology Matters:
Potential Reversibility of Mild Cognitive Impairment Sarah E. Cote and Lisa
D. Ravdin. 3. Drugs and Substance Abuse Jakob Thorn, Doug Johnson-Greene,
and Cady Block. 4. Medication Effects: The Cognitive Impact of Drug
Classes, Polypharmacy, and Drug Interactions. Eric Silk and Dawson Hedges
5. Depression and Other Psychiatric Presentations Shawn McClintock and
Allison Gregg. 6. Persistent Pain Yana Suchy, Michelle Gereau Mora, and
Libby A. DesRuisseaux. 7. Metabolic Disorders and Reversible Causes of
Cognitive Dysfunction Margaret E. Wiggins, and Marc A. Norman. 8. Brain
Tumors Jennifer L. Nosker and Michael W. Parsons. 9. Infectious Diseases
and Dementia: Potential Interventions for Prevention and Treatment Morgan
Chase McClellan, Ethan Sage, Jonathan D. Moore, Shawn D. Gale, Dawson W.
Hedges, and Thomas J. Farrer. 10. Normal Pressure Hydrocephalus Drew M.
Hodis, Jennifer S. Shalam, Wei-Qian Wang, and Susan Farella-Busch. 11.
Other Medical Illnesses and Cognitive Impairment Eric M. Watson, Amelia J.
Hicks, and Jacqueline H. Becker. 12. The mpact of Sleep and Sleep Disorders
on Cognitive Health: Reversibility of Cognitive Impairment Associated with
Sleep Disorders Mariya Narizhnaya and Matthew R. Ebben. 13. Concepts of
Multimorbidity in Clinical Neuropsychology Jason W. Krellman and Robert
Leavenworth. 14. Delirium Kirk J. Stucky and Tracy Shannon. 15. Conclusion
and Applications Thomas J. Farrer and FLynn A. Schaefer.
Dementia Lynn A. Schaefer and Thomas J. Farrer. 2. Etiology Matters:
Potential Reversibility of Mild Cognitive Impairment Sarah E. Cote and Lisa
D. Ravdin. 3. Drugs and Substance Abuse Jakob Thorn, Doug Johnson-Greene,
and Cady Block. 4. Medication Effects: The Cognitive Impact of Drug
Classes, Polypharmacy, and Drug Interactions. Eric Silk and Dawson Hedges
5. Depression and Other Psychiatric Presentations Shawn McClintock and
Allison Gregg. 6. Persistent Pain Yana Suchy, Michelle Gereau Mora, and
Libby A. DesRuisseaux. 7. Metabolic Disorders and Reversible Causes of
Cognitive Dysfunction Margaret E. Wiggins, and Marc A. Norman. 8. Brain
Tumors Jennifer L. Nosker and Michael W. Parsons. 9. Infectious Diseases
and Dementia: Potential Interventions for Prevention and Treatment Morgan
Chase McClellan, Ethan Sage, Jonathan D. Moore, Shawn D. Gale, Dawson W.
Hedges, and Thomas J. Farrer. 10. Normal Pressure Hydrocephalus Drew M.
Hodis, Jennifer S. Shalam, Wei-Qian Wang, and Susan Farella-Busch. 11.
Other Medical Illnesses and Cognitive Impairment Eric M. Watson, Amelia J.
Hicks, and Jacqueline H. Becker. 12. The mpact of Sleep and Sleep Disorders
on Cognitive Health: Reversibility of Cognitive Impairment Associated with
Sleep Disorders Mariya Narizhnaya and Matthew R. Ebben. 13. Concepts of
Multimorbidity in Clinical Neuropsychology Jason W. Krellman and Robert
Leavenworth. 14. Delirium Kirk J. Stucky and Tracy Shannon. 15. Conclusion
and Applications Thomas J. Farrer and FLynn A. Schaefer.







